Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

SLGC - SomaLogic, Inc.

IEX Last Trade
2.13
-0.090   -4.225%

Share volume: 947,634
Last Updated: Tue 08 Aug 2023 09:59:58 PM CEST
Testing Laboratories: -3.17%

PREVIOUS CLOSE
CHG
CHG%
$2.22
-0.09
-4.05%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
10%
Profitability 0%
Dept financing 18%
Liquidity 75%
Performance 1%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-9.39%
1 Month
1.83%
3 Months
-23.71%
6 Months
-35.65%
1 Year
-56.39%
2 Year
-80.68%
Key data
Stock price
$2.13
P/E Ratio 
0.00
DAY RANGE
N/A - $2.22
EPS 
$0.00
52 WEEK RANGE
$1.98 - $4.73
52 WEEK CHANGE
-$0.52
MARKET CAP 
417.239 M
YIELD 
N/A
SHARES OUTSTANDING 
187.945 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
1.74
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$814,260
AVERAGE 30 VOLUME 
$829,768
Company detail
CEO: Roy Smythe
Region: US
Website: somalogic.com
Employees: 320
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Testing Laboratories
Sector: Professional, Scientific, and Technical Services

SomaLogic, Inc. develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein. It offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples.

Recent news